BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang HS, Onos KD, Choi K, Keezer KJ, Skelly DA, Carter GW, Howell GR. Natural genetic variation determines microglia heterogeneity in wild-derived mouse models of Alzheimer's disease. Cell Rep 2021;34:108739. [PMID: 33567283 DOI: 10.1016/j.celrep.2021.108739] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Sun J, Song Y, Chen Z, Qiu J, Zhu S, Wu L, Xing L. Heterogeneity and Molecular Markers for CNS Glial Cells Revealed by Single-Cell Transcriptomics. Cell Mol Neurobiol 2021. [PMID: 34704168 DOI: 10.1007/s10571-021-01159-3] [Reference Citation Analysis]
2 Gurdon B, Kaczorowski C. Pursuit of precision medicine: Systems biology approaches in Alzheimer's disease mouse models. Neurobiol Dis 2021;161:105558. [PMID: 34767943 DOI: 10.1016/j.nbd.2021.105558] [Reference Citation Analysis]
3 Territo PR, Zarrinmayeh H. P2X7 Receptors in Neurodegeneration: Potential Therapeutic Applications From Basic to Clinical Approaches. Front Cell Neurosci 2021;15:617036. [PMID: 33889073 DOI: 10.3389/fncel.2021.617036] [Reference Citation Analysis]
4 Clark GT, Yu Y, Urban CA, Fu G, Wang C, Zhang F, Linhardt RJ, Hurley JM. Circadian control of heparan sulfate levels times phagocytosis of amyloid beta aggregates. PLoS Genet 2022;18:e1009994. [PMID: 35143487 DOI: 10.1371/journal.pgen.1009994] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
5 Arnoux A, Ayme-Dietrich E, Dieterle S, Goy MA, Schann S, Frauli M, Monassier L, Dupuis L. Evaluation of a 5-HT2B receptor agonist in a murine model of amyotrophic lateral sclerosis. Sci Rep 2021;11:23582. [PMID: 34880312 DOI: 10.1038/s41598-021-02900-0] [Reference Citation Analysis]
6 Frenger MJ, Hecker C, Sindi M, Issberner A, Hartung HP, Meuth SG, Dietrich M, Albrecht P. Semi-Automated Live Tracking of Microglial Activation in CX3CR1GFP Mice During Experimental Autoimmune Encephalomyelitis by Confocal Scanning Laser Ophthalmoscopy. Front Immunol 2021;12:761776. [PMID: 34745138 DOI: 10.3389/fimmu.2021.761776] [Reference Citation Analysis]
7 Vavougios GD, Breza M, Mavridis T, Krogfelt KA. FYN, SARS-CoV-2, and IFITM3 in the neurobiology of Alzheimer's disease. Brain Disorders 2021;3:100022. [DOI: 10.1016/j.dscb.2021.100022] [Reference Citation Analysis]
8 Neuner SM, Telpoukhovskaia M, Menon V, O’connell KM, Hohman TJ, Kaczorowski CC. Translational approaches to understanding resilience to Alzheimer’s disease. Trends in Neurosciences 2022. [DOI: 10.1016/j.tins.2022.02.005] [Reference Citation Analysis]
9 Wang H. Microglia Heterogeneity in Alzheimer's Disease: Insights From Single-Cell Technologies. Front Synaptic Neurosci 2021;13:773590. [PMID: 35002670 DOI: 10.3389/fnsyn.2021.773590] [Reference Citation Analysis]
10 Chen YA, Lu CH, Ke CC, Chiu SJ, Jeng FS, Chang CW, Yang BH, Liu RS. Mesenchymal Stem Cell-Derived Exosomes Ameliorate Alzheimer's Disease Pathology and Improve Cognitive Deficits. Biomedicines 2021;9:594. [PMID: 34073900 DOI: 10.3390/biomedicines9060594] [Cited by in F6Publishing: 3] [Reference Citation Analysis]